Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lifeist Wellness Inc V.LFST

Alternate Symbol(s):  LFSWF

Consumer Defensive Food Distribution Cannabis Health Care
Lifeist Wellness Inc. is a Canada-based health-tech company. The Company leverages advancements in science and technology to develop innovative products to support human wellness and transform lives. The Company's key asset is its United States biosciences subsidiary Mikra Cellular Sciences Inc. (Mikra), a biosciences and consumer wellness company focused on developing and selling products. Mikra's products consists of Focus, Protect, Serenity, and CELLF.


TSXV:LFST - Post by User

Lifeist Wellness Inc > CELLF 173% growth Q3 vs.Q4
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(104)
•••
Post by Rockets2021on Sep 15, 2022 5:33pm
101 Views
Post# 34965558

CELLF 173% growth Q3 vs.Q4

CELLF 173% growth Q3 vs.Q4"Mikra Cellular Sciences Inc. (“Mikra”) has increased its active monthly subscriber count by 173% in Q3 2022 compared to Q2 2022 for CELLFTM, its first product which combats brain fog and unlocks healthy aging at a cellular level. This level of compounding growth highlights Mikra’s ambition to carve out a significant segment of the emerging cellular health category."
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities